In addition orally to the phase 2 study abstract today at the conference.

In addition orally to the phase 2 study abstract today at the conference. Presented Tanox an abstract highlighting in vitro results TNX-355 activity against enfuvirtide – resistant HIV , abstracts and slides from the oral presentation are available on the Tanox website ().

About Tanox,Tanox is a biotechnology company focused on the development of monoclonal antibodies. The company develops innovative pharmaceuticals for the treatment of autoimmune diseases, Inflammation, infectious disease and cancer. Tanox first approved drug, Xolair is the first antibody approved to treat moderate to severe allergic asthma confirmed. Xolair was developed in collaboration with Genentech, and Novartis Pharma AG and is in the United States in the United States, Canada and major European countries. Tanox in Houston and has a manufacturing facility in San Diego. Additional company information can be found at.

The number of adverse events reported for the TNX-355 treatment arms not reported was not statistically reported on the number of the placebo group.Create gaps in financing for state Medicaid programs a total of to $ 849,000 in the coming two years Increase as government revenue, the collar reduces its share of of the Finance. Twenty-nine States are to receive an estimated $ 579,000 lower to Medicaid from the federal budget year from 1 October 2006, obtaining the greatest number of State at less federal funds to least five years. In addition, nine states will receive more federal funding, the lowest number since 2000 (Messina, AP / Arkansas Democrat-Gazette.. ‘Image courtesy of you can entire Kaiser Daily Health Policy is indicate Reports, search the archives and sign up for email service to Kaiser Daily Health policy coverage publish Reproduction to royal network free service by The Henry J. Kaiser Family Foundation 2005 Advisory Board Company and Kaiser Family Foundation, All rights reserved.

IL ‘ all new all Kids program, eg, low-cost health insurance for children in the Family with incomes will be too high order qualify to Medicaid but too small to to afford health coverage. However, reported to the financial year topic in that Medicare costs. Risen 7.5 percent in 2005 and further increases are determined for next year During state governments pay about half the cost for Medicaid, that additional burden being be expected some some celebrating new law editions the coming financial year, told of the PO tells. Executive Director of Executive Director Scott Pattison said: The remembrance of the really poor downturn we have did from 2002 to 2004 is strongly And there is always Medicare and many States wish goes in building up their rainy day Fund in the event of economy softened.